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Translation and validation of two 
Chinese health-related quality of life 
instruments in patients with coronary 
heart disease
Key Messages
1. The Chinese version of the 27-item 
MacNew health-related quality of 
life (HRQL) questionnaire is a valid, 
reliable and responsive core coronary 
heart disease (CHD)–specific HRQL 
measure. It can be used to compare the 
health outcomes, burdens of illness, and 
treatment effectiveness in pure or mixed 
populations of patients with myocardial 
infarction, angina, or heart failure in 
clinical trials and in routine clinical 
practice.
2. The Chinese version of the 35-item 
Myocardial Infarction Dimensional 
Assessment Scale (MIDAS) did not 
perform as well. Although four of 
the seven subscales, which cover the 
physical and psychosocial aspects of 
HRQL, are psychometrically sound 
when used to evaluate HRQL among 
CHD patients with different cardiac 
diagnostic categories, the remaining 
three subscales covering treatment-
related aspects are not. The latter had 
only weak validity and responsiveness, 
which may be due to cultural 
differences.
3. To improve the overall performance 
of the Chinese version of the MIDAS, 
further effort is required to clarify the 
treatment-related impact of CHD on well 
being from the patient’s perspective.
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Introduction
The prevalence of coronary heart disease (CHD) is increasing in Asia, including 
Hong Kong and mainland China, where it is a major cause of death and disability.1 
Patients with CHD are typically diagnosed by physician with one or more of 
three inter-related (but clinically distinct) conditions: myocardial infarction (MI), 
angina pectoris, or heart failure. This diagnostic conceptualisation has led to 
important increases in specific treatments with researchers increasingly focusing 
their attention on comparing the efficacy of one intervention with another among 
homogeneous groups of patients meeting explicit diagnostic criteria. Comparing 
the burden of illness and treatment effectiveness for CHD across the spectrum 
of patients with frequently co-occurring conditions, such as MI, angina pectoris 
or heart failure, requires a common outcome measure. Yet, a major limitation 
of existing condition-specific health-related quality of life (HRQL) instruments 
is that they are not suitable for making comparisons across different CHD 
diagnoses.
 The purpose of this study was to translate the MacNew health-related quality 
of life questionnaire2 (MacNew) and the Myocardial Infarction Dimensional 
Assessment Scale3 (MIDAS) into Chinese, and to examine their psychometric 
properties in Chinese patients with differential diagnoses of CHD, including MI, 
angina pectoris or heart failure.
Methods
Study design
This was a longitudinal study.
Subjects and settings
A convenience sample of 39 patients with evidence of CHD was recruited 
from the cardiac unit of a regional hospital between December 2004 and 
February 2006. Of these, 365 (MI: 117; angina: 154; heart failure: 94) 
completed all the study instruments; 92 of the latter were randomly selected 
for 7-day post-test assessment with the tested instruments, and the 3-month 
repeat data collection was completed in 363. The mean age of the patients was 
65 (standard deviation, 12) years, with more heart failure patients being older 
(P=0.009). The male-to-female ratio was lower among patients with heart 
failure (2:1) than MI or angina (4:1).
Main study instruments
The 27-item C-MacNew and the 35-item C-MIDAS were translated from their 
original English versions by using Brislin’s model of forward and backward 
translation. Based on a 7-point and 5-point Likert scale, the C-MacNew and the 
C-MacNew examine CHD disease–specific quality of life in three (physical, 
emotional, and social) and seven (physical activity, insecurity, emotional 
reaction, dependency, diet, concerns over medication, side-effects) dimensions, 
respectively. Previous studies have demonstrated high validity and reliability for 
both of these instruments.
Validation of two Chinese health-related quality of life instruments
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Translation and validation plan
1. The reliability of the C-MacNew and the C-MIDAS was 
determined by examining their internal consistency and 
7-day test-retest reliability with Cronbach’s alpha and 
intraclass correlation coefficient, respectively.
2. Construct validity of the C-MacNew and the C-MIDAS 
was established by computing their correlations with 
the Short-Form 36-item Health Survey (SF-36) and 
the Hospital Anxiety and Depression Scale (HADS). 
Confirmatory factor analysis was also used to determine 
whether the C-MacNew and the C-MIDAS conform to 
the factor structure of their respective original versions.
3. Discriminatory validity was determined by using the 
logic of ‘known-groups’ approach, using age, gender, 
the presence or absence of anxiety and depression 
according to the HADS score, and perceived health 
deterioration (according to the health transition item of 
the SF-36) as discriminative variables. 
4. Longitudinal validity was determined by examining the 
correlations of the changes in the C-MacNew and the 
C-MIDAS scores with the changes in the SF-36 scores 
over a 3-month period.
5. Responsiveness of the C-MacNew and the C-MIDAS 
was determined by computing the effect size and 
standardised response mean for the changes of scores 
over a 3-month period.
RESULTS
Reliability
The results suggest good internal consistency for the C-
MacNew and the C-MIDAS in measuring HRQL for 
patients with different cardiac diagnostic categories, 
though the Cronbach’s alphas for the ‘side-effects’ and 
‘dependency’ subscales of the C-MIDAS were slightly 
lower than the criterion level in heart failure patients (Table 
1). Both the instruments are reproducible, with intraclass 
correlation coefficient ranged from 0.88-0.93 and 0.72-
0.92, respectively.
Validity
The construct validity of the C-MacNew and the C-MIDAS 
(except the ‘diet’, ‘concerns over medication’ and ‘side-
effects’) was supported by their significant moderate-to-
strong correlations with both SF-36 physical and mental 
component scores and the HADS anxiety and depression 
scores (Table 2). Results of confirmatory factor analysis also 
indicated that the C-MacNew (χ2/df=1.41, RMSEA=0.043, 
NFI=0.93, NNFI=0.94 and CFI=0.95) and C-MIDAS (χ2/
df=2.32, RMSEA=0.059, NFI=0.94, NNFI=0.95, CFI=0.96) 
conformed to the original 3-factor and 7-factor structure, 
respectively. However, the measurement model of the C-
MacNew suggested that there was only one item (instead 
of 12 items in the original version) that loaded significantly 
onto more than one subscale, whereas that of the C-MIDAS 
suggested the existence of error covariance between item 2 
(had angina symptom) and item 3 (had angina that affected 
life).
 The results of discriminative validity indicated that 
both the C-MacNew and the C-MIDAS (except for ‘diet’, 
‘concerns over medication’, ‘side-effects’ subscales) 
identified poorer HRQL in MI or angina patients who 
reported anxiety and perceived deteriorated health. Both 
instruments also identified a significantly poorer HRQL in 
female patients with angina. As for heart failure patients, the 
C-MacNew and two subscales of the C-MIDAS scores (ie 
‘physical activity’ and ‘insecurity’) indicated significantly 
poorer HRQL in patients who were female, at old age, with 
anxiety and with perceived health deterioration.
 Longitudinal validity of the C-MacNew and the 
C-MIDAS was also established as the changes in the 
majority of the subscales’ scores showed a significant 
and moderate relationship with the changes in the SF-36 
physical and mental component scores over a 3-month 
period. Nevertheless, three C-MIDAS subscales which 
had low discriminative validity (ie ‘diet’, ‘concerns over 
medication’, ‘side-effects’) also had poor performance on 
longitudinal validity testing (Table 3).
Responsiveness
The mean changes in the C-MacNew and C-MIDAS scores 
were statistically significant (P<0.001) in the three cardiac 
diagnostic groups. The results indicated a moderate-to-
strong responsiveness of C-MacNew in detecting changes 
in HRQL (effect size: 0.51-0.7; standardised response 
mean: 0.53-0.7) in all the three cardiac diagnostic groups. 
This was also true for most of the C-MIDAS subscales 
(effect size: 0.43-0.94; standardised response mean: 0.46-
0.96), with the exception of ‘concerns over medication’ and 
‘side-effects’ subscales (effect size, 0.20-0.3; standardised 
response mean, 0.21-0.37).
Discussion
This study substantiates previously published psychometric 
data on the original versions of MacNew and MIDAS 
Instruments Myocardial 
infarction
Angina Heart 
failure
C-MacNew 
Overall scale 0.91 0.94 0.94
Physical 0.86 0.89 0.88
Emotion 0.90 0.92 0.92
Social 0.88 0.91 0.90
C-MIDAS
Overall scale 0.94 0.95 0.93
Physical activity 0.90 0.92 0.87
Insecurity 0.95 0.94 0.92
Emotional reaction 0.86 0.90 0.88
Dependency 0.78 0.79 0.65
Diet 0.88 0.85 0.90
Concerns over medication 0.79 0.82 0.70
Side-effects 0.70 0.77 0.67
Table 1. Reliability of Chinese versions of MacNew health-
related quality of life questionnaire (C-MacNew) and the 
Myocardial Infarction Dimensional Assessment Scale (C-
MIDAS)
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Instruments Myocardial infarction Angina Heart failure
Correlation with Short-Form 36-item Health Survey (SF-36) physical component scores
C-MacNew: physical 0.60‡ 0.62‡ 0.64‡
C-MacNew: emotional 0.48‡ 0.47‡ 0.50‡
C-MacNew: social 0.55‡ 0.55‡ 0.57‡
C-MIDAS: physical activity -0.61† -0.69† -0.71†
C-MIDAS: insecurity -0.43† -0.56† -0.54†
C-MIDAS: emotional reaction -0.28† -0.39† -0.41†
C-MIDAS: dependency -0.43† -0.47† -0.50†
C-MIDAS: diet -0.17§ -0.12§ -0.04§
C-MIDAS: concerns over medication -0.22* -0.16§ -0.07§
C-MIDAS: side-effects -0.29† -0.29† -0.07§
Correlation with SF-36 mental component scores
C-MacNew: physical 0.58‡ 0.56‡ 0.66‡
C-MacNew: emotional 0.59‡ 0.59‡ 0.70‡
C-MacNew: social 0.56‡ 0.57‡ 0.66‡
C-MIDAS: physical activity -0.54† -0.63† -0.58†
C-MIDAS: insecurity -0.44† -0.62† -0.58†
C-MIDAS: emotional reaction -0.46† -0.53† -0.58†
C-MIDAS: dependency -0.48† -0.46† -0.46†
C-MIDAS: diet -0.22* -0.07§ -0.12§
C-MIDAS: concerns over medication -0.30† -0.13§ -0.27†
C-MIDAS: side-effects -0.29† -0.16* -0.26†
Correlation with Hospital Anxiety and Depression Scale (HADS) anxiety score
C-MacNew: physical -0.44‡ -0.47‡ -0.37‡
C-MacNew: emotional -0.67‡ -0.68‡ -0.59‡
C-MacNew: social -0.47‡ -0.50‡ -0.44‡
C-MIDAS: physical activity 0.39‡ 0.38‡ 0.32†
C-MIDAS: insecurity 0.59‡ 0.56‡ 0.51‡
C-MIDAS: emotional reaction 0.58‡ 0.49‡ 0.46‡
C-MIDAS: dependency 0.49‡ 0.46‡ 0.45‡
C-MIDAS: diet -0.06§ -0.01§ -0.20§
C-MIDAS: concerns over medication 0.28† 0.21† 0.16§
C-MIDAS: side-effects 0.17§ 0.25† 0.23*
Correlation with HADS depression score
C-MacNew: physical -0.53‡ -0.55‡ -0.61‡
C-MacNew: emotional -0.80‡ -0.75‡ 0.70‡
C-MacNew: social -0.56‡ -0.59‡ -0.67‡
C-MIDAS: physical activity 0.47‡ 0.47‡ 0.57‡
C-MIDAS: insecurity 0.62‡ 0.54‡ 0.53‡
C-MIDAS: emotional reaction 0.53‡ 0.34‡ 0.36‡
C-MIDAS: dependency 0.48‡ 0.37‡ 0.49‡
C-MIDAS: diet 0.02§ -0.02§ 0.02§
C-MIDAS: concerns over medication 0.36‡ 0.18* 0.05§
C-MIDAS: side-effects 0.23* 0.25† -0.01§
Table 2. Construct validity of Chinese versions of MacNew health-related quality of life questionnaire (C-MacNew) and the 
Myocardial Infarction Dimensional Assessment Scale (C-MIDAS)
* P<0.05
† P<0.01
‡ P<0.001
§ Not significant
Instruments Changes in Short-Form 36-item Health Survey
Physical component score Mental component score
Myocardial infarction Angina Heart failure Myocardial infarction Angina Heart failure
Changes in C-MacNew
Physical 0.63‡ 0.66‡ 0.65‡ 0.53‡ 0.59‡ 0.58‡
Emotion 0.58‡ 0.48‡ 0.51‡ 0.58‡ 0.58‡ 0.61†
Social 0.58‡ 0.62‡ 0.54‡ 0.55‡ 0.56‡ 0.62‡
Changes in C-MIDAS 
Physical activity -0.61‡ -0.57‡ -0.57‡ -0.47‡ 0.60‡ 0.50‡
Insecurity -0.31‡ -0.45‡ -0.45‡ -0.30† 0.58‡ 0.47‡
Emotional reaction -0.26† -0.33‡ -0.40‡ -0.34‡ 0.48‡ 0.41‡
Dependency -0.24* -0.41‡ -0.52‡ -0.39‡ 0.30‡ 0.35†
Diet -0.93§ 0.05§ -0.01§ -0.12§ 0.13§ 0.25*
Concerns over medication -0.22* -0.02§ -0.24* -0.22* 0.10§ 0.31†
Side-effects -0.16§ -0.06§ -0.12§ -0.26† 0.12§ 0.20§
Table 3. Longitudinal validity of Chinese versions of MacNew health-related quality of life questionnaire (C-MacNew) and the 
Myocardial Infarction Dimensional Assessment Scale (C-MIDAS)
* P<0.05
† P<0.01
‡ P<0.001
§ Not significant
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in CHD patients. Both of these instruments are internally 
consistent and reproducible in Chinese patients in each of 
the three CHD diagnostic groups (MI, angina, and heart 
failure). Their factor structures are similar to those of their 
respective original versions for measuring the various aspects 
of HRQL among CHD patients. C-MacNew and four of the 
seven subscales of C-MIDAS (physical activity, insecurity, 
emotional reactions, dependency) demonstrated good 
construct and longitudinal validity. They are also responsive 
to detecting changes in HRQL in the three cardiac diagnostic 
groups. All these findings provide strong evidence to suggest 
that the C-MacNew may have value as a core questionnaire 
in patients with a differential diagnosis of CHD.
 As for C-MIDAS, the poor performance of the three 
subscales (diet, concerns over medication and side-effects) 
may be related to concerns about risk factors for CHD and 
worries about medical treatment that patients regard as less 
important in interpreting disease impact and life situations.4 
Some studies also found that CHD patients did not consider 
adjusting their lifestyle in order to reduce CHD risk factors 
as important. Such an attitude might be more prominent in 
the current sample, as older people in Chinese culture tend 
to adopt a ‘do nothing approach’ and allow fate to take its 
course.5 As for the ‘side-effects’ subscale, the items such as 
‘felt the cold more’ and ‘unwanted side-effect’ might not be 
specific enough to assess patients’ problems associated with 
medical treatment. Although the study provides evidence 
of adequate psychometric properties of only four of the 
Chinese MIDAS subscales, these four subscales provide 
a wide coverage of the physical and psychosocial health 
and functioning of CHD patients. As the original MIDAS 
suggests the use of subscale scores, these subscales can be 
used as an independent, reliable, valid and responsive core 
CHD-specific HRQL measure among patients in different 
diagnostic categories. Improving the performance of the 
Chinese MIDAS requires further effort to clarify patients’ 
perspectives of treatment-related impact of CHD on well 
being.
 This study has limitations. First, recruiting a consecutive 
sample of CHD patients managed in a single acute care 
setting may limit the generalisability of the findings for 
patients in community-dwelling or rehabilitative settings. 
Second, the over-representation of male patients in the 
sample further threatens the external validity of the findings. 
Finally, as we only collected 7-day post-test data from 25% 
of the patients, the reproducibility of the C-MacNew and 
the C-MIDAS could not be examined for each cardiac 
diagnostic group individually.
Conclusions
In conclusion, there is sufficient evidence that the 
psychometric properties of the C-MacNew and some of 
the subscales of the C-MIDAS are adequate to warrant 
recommending these HRQL instruments for Chinese patients 
with MI, angina or heart failure as an outcome measure to 
enhance treatment evaluation for patients with CHD. They 
can be used to compare health outcomes, burden of illness, 
and treatment effectiveness on pure or mixed populations 
with the three previously mentioned cardiac diagnoses.
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